Related Experiment Video
Updated: May 13, 2026
07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
CDK2 knockdown enhances head and neck cancer cell radiosensitivity
Ahmed Soffar1, Katja Storch, Eiman Aleem
1OncoRay - National Center for Radiation Research in Oncology, Medical Faculty Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, Germany.
International Journal of Radiation Biology
|March 7, 2013
Summary
Targeting cyclin-dependent kinase 2 (CDK2) increases radiosensitivity in head and neck squamous cell carcinoma (HNSCC) cells grown in 2D cultures. However, this effect is lost in 3D environments, suggesting further research is needed for radiotherapy applications.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy Research
Background:
- Cyclin-dependent kinase 2 (CDK2) plays a key role in cell cycle regulation.
- CDK2 is a potential therapeutic target in cancer treatment.
- The impact of CDK2 targeting on tumor cell radiosensitivity remains unclear.
Purpose of the Study:
- To investigate the effect of CDK2 targeting on the radiosensitivity of human head and neck squamous cell carcinoma (HNSCC) cells.
- To determine if CDK2 inhibition alters DNA damage repair and cell cycle progression following irradiation.
Main Methods:
- Utilized CDK2 knockout (CDK2(-/-)) and wild-type (WT) mouse embryonic fibroblasts (MEF).
- Employed small interfering RNA (siRNA) for CDK2 knockdown in six HNSCC cell lines.
- Assessed colony formation, DNA double-strand breaks (DSB), cell cycle distribution, and protein expression/phosphorylation.
Main Results:
- CDK2(-/-) MEF and CDK2-knockdown HNSCC cells exhibited increased radiosensitivity compared to controls.
- CDK2 targeting attenuated the repair of DNA double-strand breaks (DSB).
- CDK2 knockdown did not alter cell cycling in irradiated SAS and FaDu cells and failed to enhance radiosensitivity in a 3D extracellular matrix model.
Conclusions:
- Targeting CDK2 demonstrates radiosensitizing effects on HNSCC cells cultured as monolayers.
- Further investigation under more physiologically relevant conditions is necessary to evaluate CDK2 as a radiotherapy target.
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...